Product portfolio

Liquid biopsy

See clearly, understand more

Liquid biopsy was not always an option for molecular laboratories due to the short 4-hour window from blood collection to cfDNA extraction, time intensive workflows, and the need for specific technical expertise.

From sample collection, polymerase chain reaction (PCR) testing, and next-generation sequencing (NGS)—Roche’s robust liquid biopsy portfolio is bringing new possibilities to clinical research and diagnostics.

Lab technician

Flexibility

Created for easy adoption

From simple PCR workflows to the turnkey NGS kit-based solution, the Roche Liquid Biopsy portfolio facilitates in-house adoption of liquid biopsy testing.

  • cfDNA collection
  • Tumor profiling
  • Surveillance for minimal residual disease - RUO
  • Longitudinal monitoring for tumor burden - RUO
illustration of blood stream

Performance

Designed to meet high quality Roche standards

  • Collection tubes providing a high degree of stability to prevent cell lysis up to 8 hours
  • Reliable PCR assays backed by robust clinical evidence
  • Ultra-sensitive NGS ctDNA tumor profiling, surveillance and monitoring assays that are purpose-built for liquid biopsy research
  • Sample stability in transit and at different temperatures
  • PCR assays run on the trusted cobas® platform
  • Fully supported by Roche’s leading service, logistics and distribution network
Individually exceptional, collectively unprecedented
DNA collection tube

Cell-Free DNA Collection Tube

Direct-draw tubes for the collection, stabilization and transportation of whole blood specimens.

Learn more
cobas EGFR

cobas® EFGR Mutation Test v2

A companion diagnostic test to identify 42 mutations in the EGFR gene, including the T790M resistance mutation.

Learn more
AVENIO ctDNA

AVENIO ctDNA Analysis Kits (RUO)

A portfolio of assay kits – all set and ready for you to use for tumor profiling and surveillance & monitoring.

Learn more
Roche BRAF/NRAS kit

BRAF/NRAS Mutation Test (LSR)

Qualitative detection and identification of mutations in the BRAF gene and the NRAS viral oncogenes.

Learn more
Roche BRAF/NRAS kit

KRAS Mutation Test v2 (LSR)

Qualitative detection and identification of 28 mutations in exons 2, 3, and 4 of the KRAS gene.

Learn more

AVENIO ctDNA Analysis Kits, Roche/AVENIO NGS liquid biopsy assays, BRAF/NRAS Mutation Test, KRAS Mutation Test v2, and the RUO version of the Roche Cell-Free DNA Collection Tube are For Research Use Only, and not for use in diagnostic procedures.

Doing now what patients need next

As the intricacies of cancer become better understood, new discoveries will follow.

From uncovering the next major breakthrough to monitoring for disease progression, the Roche liquid biopsy portfolio can help make your vision of personalized patient care a reality.

RUO: Research Use Only
LSR: Life Science Research

illustration of blood stream
Found 0 results in
Filters
...
    ...